Throughout history, the world's problems have been solved by people working together for a common goal. Cancer is no different. Treatment is moving forward at a rapid pace; every day there are significant new developments that improve outcomes and make life better for patients around the world. But the fact is that no one can do it alone. The greatest innovations come from collaboration, when clinics, universities and industry share knowledge, inspire each other and form partnerships to find new possibilities. RaySearch is committed to collaboration and knowledge sharing. We work with clinics, manufacturers, technology companies and cross-industry groups to do the best we can to conquer cancer. By working on different aspects and sharing what we know, we can make it happen. We make a firm commitment to our partners, which includes a promise to ensure ongoing compatibility, for example by supporting hardware developments and new features into the future.
Accuray and RaySearch have a long-term collaboration agreement to develop and market fully integrated solutions combining RayStation and RayCare with the TomoTherapy, CyberKnife and Radixact treatment delivery systems. This partnership enables greater flexibility in clinics with multiple treatment machines. Integration with RayCare brings the additional advantage of an independent OIS.
United Imaging Healthcare (UIH)
One of RaySearch’s latest strategic collaborations is with UIH, founded in 2011 in Shanghai, China. UIH has developed the world’s first medical linear accelerator with fully integrated diagnostic-quality CT imaging, designed from the ground up to support adaptive therapy planning. As part of the collaboration, RaySearch will adapt RayStation and RayCare to UIH’s CT linac and standard linac.
RaySearch and IBA, the global leader of proton therapy solutions, have a long-term strategic alliance since many years back. As part of the collaboration, RaySearch has customized RayStation and RayCare for IBA delivery solutions, and together we supply a complete solution for all software and hardware to deliver outstanding adaptive proton therapy treatment. This allows clinics worldwide to make better use of the strength of IBA's treatment machines for a large number of clinical indications.
ProNova Solutions, LLC. provides proton therapy solutions for cancer treatment worldwide. Its ProNova SC360 proton therapy solution uses superconducting magnet technology in the cyclotron and treatment gantry to reduce the size, weight and power required to deliver proton therapy treatment. The company was incorporated in 2011 and is based in Knoxville, Tennessee.
Mevion Medical Systems
Mevion Medical Systems is a leading manufacturer of compact proton therapy systems. As part of the ongoing collaboration, RayStation development incorporates support for the latest features of Mevion treatment systems, such as HYPERSCAN technology.
Advanced Oncotherapy PLC (AVO)
AVO is a UK-based developer of proton therapy technology. The LIGHT system is a modular proton therapy system developed in a collaboration with CERN in Geneva, Switzerland. The system is using a linear accelerator that enables narrower beams, with features including multiple spot sizes and fast energy switching time. RayStation, RayCommand and RayCare will fully support the LIGHT system.
Eckert & Ziegler BEBIG
Eckert & Ziegler BEBIG is a European supplier of products for brachytherapy: a radiation therapy technique in which a small radioactive implant is inserted into the patient’s tissue, directly into the tumor or close to it. Brachytherapy is most commonly used in treating prostate cancer but can be applied to many other areas, including cancers of the brain, eye, lung and skin. Both RayStation and RayCare will be integrated with the Eckert & Ziegler BEBIG brachytherapy systems.
Canon Medical Systems Corporation develops diagnostic imaging systems including CT, MRI, ultrasound, X-ray systems and clinical laboratory systems. Our collaboration will generate products to enable a more efficient workflow in the process of virtual simulation. These imaging and planning tools will assist clinicians in deciding how and where patients should be treated, determining size and location of the tumor, planning beam directions and calculating isocenter locations.
BORON NEUTRON CAPTURE THERAPY (BNCT)
Sumitomo Heavy Industries, Ltd., based in Tokyo, Japan, has developed the world's first accelerator-based system for clinical BNCT – an advanced form of radiation therapy that targets cancer at the cellular level, destroying tumor cells with minimal damage to adjacent healthy tissue. Users of BNCT will have access to the full range of advanced functionality in RayStation.
Neutron Therapeutics is a global company with locations in the US and Finland. The company has developed a complete single-room solution for BNCT, including an accelerator-based neutron source, treatment room equipment, and a dose engine interface to RayStation. The first installation of the system will be at Helsinki University Hospital.
IBA Dosimetry is a subsidiary to IBA and a leading supplier of advanced dosimetry and quality-assurance solutions for clinical and industrial applications of radiation physics. In 2006, RaySearch signed a long-term development and licensing agreement with IBA Dosimetry regarding a suite of products for quality assurance in IMRT and adaptive therapy. The agreement represented an important expansion of RaySearch’s business and products from the partnership are marketed under the COMPASS® brand.